(Q35077096)

6 August 2017

1 reference

title

Cytokines and depression: the need for a new paradigm (English)

1 reference

6 August 2017

Robert Dantzer

1 reference

6 August 2017

Lucile Capuron

1 reference

6 August 2017

language of work or name

1 reference

1 February 2003

1 reference

Brain, Behavior, and Immunity

6 August 2017

published in

1 reference

6 August 2017

volume

17 Suppl 1

1 reference

6 August 2017

page(s)

S119-24

1 reference

Differential effects of interleukin (IL)-1beta, IL-2 and IL-6 on responding for rewarding lateral hypothalamic stimulation

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2802%2900078-8

7 January 2021

Endocrine and cytokine correlates of major depression and dysthymia with typical or atypical features

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2802%2900078-8

7 January 2021

Inflammation, depressive symptomtology, and coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2802%2900078-8

7 January 2021

Prediction of the depressive effects of interferon alfa therapy by the patient's initial affective state.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2802%2900078-8

7 January 2021

Early depressive symptoms in cancer patients receiving interleukin 2 and/or interferon alfa-2b therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2802%2900078-8

7 January 2021

Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2802%2900078-8

7 January 2021

Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2802%2900078-8

7 January 2021

Chronic treatment with the atypical antidepressant tianeptine attenuates sickness behavior induced by peripheral but not central lipopolysaccharide and interleukin-1beta in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2802%2900078-8

7 January 2021

Olfactory bulbectomy provokes a suppression of interleukin-1beta and tumour necrosis factor-alpha production in response to an in vivo challenge with lipopolysaccharide: effect of chronic desipramine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2802%2900078-8

7 January 2021

Cytokines and depression: fortuitous or causative association?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2802%2900078-8

7 January 2021

Cytokine-induced sickness behavior: mechanisms and implications

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2802%2900078-8

7 January 2021

The reductions in sweetened milk intake induced by interleukin-1 and endotoxin are not prevented by chronic antidepressant treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2802%2900078-8

7 January 2021

Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2802%2900078-8

7 January 2021

Central monoamine and plasma corticosterone changes induced by a bacterial endotoxin: sensitization and cross-sensitization effects

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2802%2900078-8

7 January 2021

The corticosteroid receptor hypothesis of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2802%2900078-8

7 January 2021

Effect of single intracerebroventricular injection of alpha-interferon on monoamine concentrations in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2802%2900078-8

7 January 2021

Effect of mild chronic stress, as a model of depression, on the immunoreactivity of C57BL/6 mice

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2802%2900078-8

7 January 2021

The role of cytokines in cancer-related fatigue

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2802%2900078-8

7 January 2021

The enzyme indoleamine 2,3-dioxygenase is induced in the mouse brain in response to peripheral administration of lipopolysaccharide and superantigen.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2802%2900078-8

7 January 2021

Cerebrospinal cytokine levels in patients with acute depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2802%2900078-8

7 January 2021

Evidence for an immune response in major depression: a review and hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2802%2900078-8

7 January 2021

Treatment with interferon-alpha (IFN alpha) of hepatitis C patients induces lower serum dipeptidyl peptidase IV activity, which is related to IFN alpha-induced depressive and anxiety symptoms and immune activation.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2802%2900078-8

7 January 2021

Interferon-mediated fatigue

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2802%2900078-8

7 January 2021

Clinical and physiological consequences of rapid tryptophan depletion

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2802%2900078-8

7 January 2021

Tryptophan depletion and depressive vulnerability

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2802%2900078-8

7 January 2021

Paroxetine for the prevention of depression induced by high-dose interferon alfa

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2802%2900078-8

7 January 2021

Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2802%2900078-8

7 January 2021

Experimental immunomodulation, sleep, and sleepiness in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2802%2900078-8

7 January 2021

Inflammatory markers in major depression and melancholia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2802%2900078-8

7 January 2021

A single administration of interleukin-1 or amphetamine induces long-lasting increases in evoked noradrenaline release in the hypothalamus and sensitization of ACTH and corticosterone responses in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2802%2900078-8

7 January 2021

The macrophage theory of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2802%2900078-8

7 January 2021

Endotoxin produces a depressive-like episode in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2802%2900078-8

7 January 2021

Effects of antidepressant drugs on the behavioral and physiological responses to lipopolysaccharide (LPS) in rodents.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2802%2900078-8

7 January 2021

Interleukin-6 increases sensitivity to the locomotor-stimulating effects of amphetamine in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2802%2900078-8

7 January 2021

Interleukin-2 potentiates novelty- and GBR 12909-induced exploratory activity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2802%2900078-8

7 January 2021

10.1016/S0889-1591(02)00078-8

Identifiers

DOI

1 reference

6 August 2017

1 reference